These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2559750)

  • 21. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles.
    Haffar OK; Smithgall MD; Moran PA; Travis BM; Zarling JM; Hu SL
    Virology; 1991 Aug; 183(2):487-95. PubMed ID: 1906660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of three enzyme immunoassays for HIV-1 antigen detection.
    Willoughby PB; Lisker A; Folds JD
    Diagn Microbiol Infect Dis; 1989; 12(4):319-26. PubMed ID: 2512047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
    Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
    Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
    Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
    Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An anti-p24 monoclonal antibody shows cross-reactivity with multiple HIV-1 proteins.
    Liang CM; Henry S; Liang SM; Epstein JS
    J Immunol Methods; 1990 Aug; 132(1):57-62. PubMed ID: 2118162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2.
    Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression Vectors for the Construction of Hybrid Ty-VLPs.
    Adams SE; Mark S; Richardson H; Kingsman SM; Kingsman AJ
    Methods Mol Biol; 1992; 8():265-76. PubMed ID: 21390719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.
    Siitari H; Turunen P; Schrimsher J; Nunn M
    J Clin Microbiol; 1990 Sep; 28(9):2022-9. PubMed ID: 2121790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.
    Klein MR; Veenstra J; Holwerda AM; Roos MT; Gow I; Patou G; Coutinho RA; De Wolf F; Miedema F
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):393-9. PubMed ID: 9075480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression.
    Lindenburg CE; Stolte I; Langendam MW; Miedema F; Williams IG; Colebunders R; Weber JN; Fisher M; Coutinho RA
    Vaccine; 2002 May; 20(17-18):2343-7. PubMed ID: 12009290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
    Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.
    Cheynet V; Verrier B; Mallet F
    Protein Expr Purif; 1993 Oct; 4(5):367-72. PubMed ID: 8251747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p24 of B- and C-subtypes.
    Gupta S; Arora K; Gupta A; Chaudhary VK
    Protein Expr Purif; 2000 Aug; 19(3):321-8. PubMed ID: 10910720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major antigenic domain recognized by monoclonal antibodies maps within the carboxy-terminal moiety of a recombinant human immunodeficiency virus-1 p24 protein.
    Gallina A; Rossi F; Mariani M; Bonelli F; Achilli G; Cattaneo E; Milanesi G
    J Med Virol; 1990 Nov; 32(3):164-70. PubMed ID: 1704049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.
    Bürgisser P; Frei PC
    Clin Exp Immunol; 1991 Aug; 85(2):219-23. PubMed ID: 1713811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
    Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
    Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.